YU174491A - Vakcine - Google Patents

Vakcine

Info

Publication number
YU174491A
YU174491A YU174491A YU174491A YU174491A YU 174491 A YU174491 A YU 174491A YU 174491 A YU174491 A YU 174491A YU 174491 A YU174491 A YU 174491A YU 174491 A YU174491 A YU 174491A
Authority
YU
Yugoslavia
Prior art keywords
vaccines
immunotherapeutic
mpl
supplemented
preparations
Prior art date
Application number
YU174491A
Other languages
English (en)
Inventor
F. Van Wijhendale
M. Slaoui
C. Bruck
M. Francotte
S. Kummert
Original Assignee
Smit Kline Beesham Biologicals (S.A)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smit Kline Beesham Biologicals (S.A) filed Critical Smit Kline Beesham Biologicals (S.A)
Publication of YU174491A publication Critical patent/YU174491A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

VAKCINE, ovaj pronalazak obezbedjuje nove, suštinski neraskidajuće oblike gp 160, i formulacije vakcine koje sadrže gp 160 ili njegov derivat, dopunjene sa 3-D Mpl. Preparati su korisni za imunoterapeutsko i imunoprofilaktično tretiranje HIV infekcija.
YU174491A 1991-03-21 1991-11-01 Vakcine YU174491A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919106048A GB9106048D0 (en) 1991-03-21 1991-03-21 Vaccines

Publications (1)

Publication Number Publication Date
YU174491A true YU174491A (sh) 1994-06-10

Family

ID=10691984

Family Applications (1)

Application Number Title Priority Date Filing Date
YU174491A YU174491A (sh) 1991-03-21 1991-11-01 Vakcine

Country Status (12)

Country Link
CN (1) CN1064891A (sh)
AP (1) AP368A (sh)
BR (1) BR9107294A (sh)
CZ (1) CZ195793A3 (sh)
FI (1) FI934133A0 (sh)
GB (1) GB9106048D0 (sh)
HU (2) HUT67011A (sh)
IL (1) IL99899A0 (sh)
MA (1) MA22381A1 (sh)
SK (1) SK82593A3 (sh)
WO (1) WO1992016556A1 (sh)
YU (1) YU174491A (sh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US6620414B2 (en) 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
PL178578B1 (pl) * 1993-03-23 2000-05-31 Smithkline Beecham Biolog Zawiesina cząstek 3-0-deacylowanego monofosforylolipidu A i sposób jej wytwarzania oraz kompozycja szczepionki zawierającej antygen w połączeniu z 3-0-deacylowanym monofosforylolipidem A i sposób jej wytwarzania
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
GB9706957D0 (en) 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
CN1304580C (zh) * 2004-07-09 2007-03-14 楼伟 重组表达人获得性免疫缺陷病毒I型的表面糖蛋白gp160
WO2006011060A2 (en) * 2004-07-23 2006-02-02 Chiron Srl Polypeptides for oligomeric assembly of antigens
NZ553776A (en) 2004-09-22 2010-05-28 Glaxosmithkline Biolog Sa Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide.
WO2008104803A2 (en) 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Proteins
EP3118221B1 (en) 2007-02-26 2019-08-21 Oxford BioTherapeutics Ltd Proteins
AU2010207552A1 (en) 2009-01-21 2011-09-01 Oxford Biotherapeutics Ltd. PTA089 protein
EP2496605A1 (en) 2009-11-02 2012-09-12 Oxford Biotherapeutics Ltd. Ror1 as therapeutic and diagnostic target
JP6113721B2 (ja) 2011-06-28 2017-04-12 オックスフォード ビオトヘラペウトイクス エルティーディー． 治療標的及び診断標的
GB201213364D0 (en) 2012-07-27 2012-09-12 Glaxosmithkline Biolog Sa Purification process
GB201213652D0 (en) 2012-08-01 2012-09-12 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
GB201302447D0 (en) 2013-02-12 2013-03-27 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
JP2018511655A (ja) 2015-03-20 2018-04-26 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ボルデテラ属に対するワクチン接種における使用のための免疫原性組成物
ES2929054T3 (es) 2016-05-16 2022-11-24 Access To Advanced Health Inst Formulación que contiene un agonista de TLR y métodos de uso
CA3023672A1 (en) 2016-05-16 2017-11-23 Infectious Disease Research Institute Pegylated liposomes and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein

Also Published As

Publication number Publication date
AP368A (en) 1994-10-28
FI934133A (fi) 1993-09-21
HU9302642D0 (en) 1994-01-28
WO1992016556A1 (en) 1992-10-01
GB9106048D0 (en) 1991-05-08
AP9100332A0 (en) 1992-01-31
MA22381A1 (fr) 1992-07-01
CZ195793A3 (en) 1994-05-18
BR9107294A (pt) 1994-06-14
HUT67011A (en) 1995-01-30
SK82593A3 (en) 1994-01-12
CN1064891A (zh) 1992-09-30
FI934133A0 (fi) 1993-09-21
IL99899A0 (en) 1992-08-18

Similar Documents

Publication Publication Date Title
YU174491A (sh) Vakcine
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
DE69620877D1 (de) Arzneimittelformulierungen für il-12
AU1955088A (en) Avirulent microbes, incapable of producing functional adenylate cyclase and cyclic AMP
TR199802329T2 (xx) Enfeksiyon hastal�klar�n�n tedavisinde IL-12 ve IFNalfa kullan�m�.
DK1104306T3 (da) Præparater af CpG- og saponinadjuvanser og fremgangsmåder til anvendelse deraf
HUP9801242A1 (hu) Hepatitis B vakcina
NO941786L (no) Uretaner og ureaer som induserer cytokinproduksjon
IL87621A0 (en) Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
NL300183I1 (nl) Acellulair vaccin.
PT97905A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados da cistina
DK0588578T3 (da) Immunogener
PT789590E (pt) Imunopotenciacao induzida por quitosano
EP0830456A4 (en) ISOLATED PROTEIN B NUCLEIC ACID MOLECULE REGULATED BY Fe (FrpB) AND VACCINE USING THE SAME
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
ATE173628T1 (de) Rapamycin-zubereitungen zur oralen verabreichung
PT600396E (pt) Vacinas contra protozoarios intestinais
WO1992006113A3 (en) Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
ES2159287T3 (es) Peptidos hemorreguladores.
HU9801705D0 (en) Streptococcus equi vaccine
DE69833568D1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
NO933628L (no) Fremgangsmaate og blanding for behandling av Herpes-infeksjoner
NO933342L (no) Derivater av gp160 og vaksiner basert paa gp160 eller et derivat derav, inneholdende et adjuvans
BG102083A (en) Compositions and methods for the detection and treatment of aids